申请人:Novo Nordisk A/S
公开号:US20150141336A1
公开(公告)日:2015-05-21
The invention relates to novel use of Pancreatic Polypeptides as well as novel Pancreatic Polypeptides and compositions thereof. Such peptides can be used in treating or preventing conditions responsive to Y4 and/or Y5 receptor activation, such as cachexia.